Westwood Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$312K Sell
259
-1
-0.4% -$1.02K 0.09% 37
2026
Q1
$239K Sell
260
-694
-73% -$704K 0.09% 40
2025
Q4
$1.03M Buy
954
+539
+130% +$515K 0.77% 39
2025
Q3
$317K Sell
415
-620
-60% -$461K 0.12% 38
2025
Q2
$807K Sell
1,035
-1,275
-55% -$991K 0.27% 33
2025
Q1
$1.91M Sell
2,310
-100
-4% -$83.2K 0.82% 19
2024
Q4
$1.86M Sell
2,410
-500
-17% -$414K 0.67% 18
2024
Q3
$2.58M Buy
2,910
+970
+50% +$872K 1.01% 15
2024
Q2
$1.76M Buy
1,940
+325
+20% +$260K 0.65% 21
2024
Q1
$1.26M Buy
+1,615
New +$1.15M 0.61% 20

Other funds holding LLY

Westwood Wealth Management's LLY Position: Q2 2026 in Review

Westwood Wealth Management reduced its Eli Lilly (LLY) stake by 0.38% in Q2 2026, selling an estimated $1.02K and leaving 259 shares worth $312K. The position accounts for 0.09% of the portfolio, ranked #37.

Westwood Wealth Management first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.58M in Q3 2024. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Westwood Wealth Management held 259 shares of Eli Lilly worth $312K as of Q2 2026.
  • Westwood Wealth Management sold 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.09% of Westwood Wealth Management's portfolio in Q2 2026, its #37 holding.
  • Westwood Wealth Management first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • Westwood Wealth Management's Eli Lilly position peaked at $2.58M in Q3 2024.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Westwood Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.